Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
Aims/hypotheses We aimed to quantify the association of individual circulating amino acids with macrovascular disease, microvascular disease and all-cause mortality in individuals with type 2 diabetes. Methods We performed a case-cohort study (N = 3587), including 655 macrovascular events, 342 microvascular events (new or worsening nephropathy or retinopathy) and 632 all-cause mortality events during follow-up, in a secondary analysis of the Action in Diabete... Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
(Version of record, pdf, 798.6KB)
- Publisher copy:
Glasgow Molecular Pathology NODE More from this funder
+ Engineering and Physical Sciences Research Council More from this funder
+ National Health and Medical Research Council of Australia More from this funderExpand funders...
- Copyright holder:
- Welsh et al
- Copyright date:
Copyright © 2018 The Authors.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record